Shira Weingarten-Gabbay, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Histocompatibility Antigens Class I | 3 | 2023 | 1338 | 1.180 |
Why?
|
| Open Reading Frames | 3 | 2022 | 809 | 0.780 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2023 | 871 | 0.750 |
Why?
|
| Protein Biosynthesis | 5 | 2024 | 2106 | 0.700 |
Why?
|
| Viruses | 1 | 2022 | 375 | 0.640 |
Why?
|
| Peptides | 5 | 2023 | 4312 | 0.620 |
Why?
|
| Genome, Viral | 3 | 2020 | 663 | 0.570 |
Why?
|
| Promoter Regions, Genetic | 3 | 2019 | 5761 | 0.530 |
Why?
|
| RNA Caps | 1 | 2016 | 76 | 0.520 |
Why?
|
| Transcription, Genetic | 2 | 2019 | 7570 | 0.420 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2019 | 1328 | 0.410 |
Why?
|
| Proteome | 1 | 2021 | 1811 | 0.380 |
Why?
|
| Genome, Human | 3 | 2019 | 4359 | 0.290 |
Why?
|
| RNA, Messenger | 6 | 2024 | 12742 | 0.280 |
Why?
|
| RNA | 1 | 2014 | 2692 | 0.240 |
Why?
|
| Codon, Initiator | 1 | 2024 | 50 | 0.230 |
Why?
|
| Gene Expression Regulation | 3 | 2019 | 11842 | 0.220 |
Why?
|
| Histocompatibility Antigens | 1 | 2023 | 453 | 0.210 |
Why?
|
| Eukaryotic Initiation Factor-4G | 1 | 2022 | 69 | 0.200 |
Why?
|
| Ribosome Subunits | 1 | 2021 | 4 | 0.200 |
Why?
|
| Sequence Analysis, DNA | 3 | 2019 | 4704 | 0.190 |
Why?
|
| Conserved Sequence | 1 | 2024 | 1172 | 0.180 |
Why?
|
| DNA | 1 | 2014 | 7199 | 0.170 |
Why?
|
| TATA Box | 1 | 2019 | 127 | 0.160 |
Why?
|
| Antigen Presentation | 2 | 2021 | 1240 | 0.160 |
Why?
|
| Transcription Factors | 2 | 2019 | 12040 | 0.160 |
Why?
|
| Mass Spectrometry | 2 | 2022 | 2171 | 0.160 |
Why?
|
| HLA Antigens | 1 | 2023 | 1340 | 0.160 |
Why?
|
| Binding Sites | 2 | 2019 | 6025 | 0.150 |
Why?
|
| 3' Untranslated Regions | 2 | 2018 | 520 | 0.140 |
Why?
|
| Sequence Analysis, RNA | 2 | 2016 | 1983 | 0.140 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2021 | 1420 | 0.140 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2019 | 3610 | 0.140 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2016 | 57 | 0.130 |
Why?
|
| Base Pairing | 1 | 2016 | 138 | 0.130 |
Why?
|
| Nucleosomes | 1 | 2019 | 480 | 0.130 |
Why?
|
| HEK293 Cells | 2 | 2021 | 4179 | 0.130 |
Why?
|
| RNA Viruses | 1 | 2016 | 110 | 0.120 |
Why?
|
| 5' Untranslated Regions | 1 | 2016 | 252 | 0.120 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2016 | 437 | 0.110 |
Why?
|
| Kinetics | 1 | 2021 | 6354 | 0.110 |
Why?
|
| Viral Proteins | 1 | 2020 | 1799 | 0.110 |
Why?
|
| RNA, Viral | 2 | 2020 | 2818 | 0.110 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2015 | 498 | 0.110 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2014 | 184 | 0.110 |
Why?
|
| Oligonucleotides | 1 | 2016 | 580 | 0.100 |
Why?
|
| Mutagenesis | 1 | 2016 | 1225 | 0.100 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 4518 | 0.090 |
Why?
|
| Alleles | 1 | 2021 | 6831 | 0.090 |
Why?
|
| Amino Acid Sequence | 1 | 2021 | 13493 | 0.080 |
Why?
|
| Environment | 1 | 2015 | 1111 | 0.080 |
Why?
|
| Humans | 13 | 2023 | 746070 | 0.070 |
Why?
|
| Genomics | 2 | 2021 | 5697 | 0.060 |
Why?
|
| Immunotherapy | 1 | 2021 | 4594 | 0.060 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2015 | 2686 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 9313 | 0.060 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 10018 | 0.060 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 2024 | 99 | 0.060 |
Why?
|
| Eukaryota | 1 | 2024 | 99 | 0.050 |
Why?
|
| Yeasts | 1 | 2024 | 281 | 0.050 |
Why?
|
| Gene Expression | 1 | 2015 | 7579 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2018 | 3744 | 0.050 |
Why?
|
| Protein Binding | 1 | 2014 | 9280 | 0.050 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2021 | 242 | 0.040 |
Why?
|
| Mammals | 1 | 2024 | 1124 | 0.040 |
Why?
|
| Molecular Sequence Annotation | 1 | 2020 | 523 | 0.040 |
Why?
|
| Nucleic Acid Conformation | 1 | 2021 | 889 | 0.040 |
Why?
|
| Animals | 4 | 2024 | 166308 | 0.040 |
Why?
|
| Rabbits | 1 | 2024 | 4783 | 0.040 |
Why?
|
| Ribosomes | 1 | 2020 | 488 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2021 | 3077 | 0.030 |
Why?
|
| Decision Trees | 1 | 2017 | 503 | 0.030 |
Why?
|
| Proteins | 2 | 2022 | 6000 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2021 | 3078 | 0.030 |
Why?
|
| Mice | 1 | 2021 | 80065 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2018 | 1531 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2017 | 1731 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2015 | 1752 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2015 | 2921 | 0.020 |
Why?
|
| Cell Line | 1 | 2020 | 15630 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2021 | 10303 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 8359 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2015 | 2288 | 0.010 |
Why?
|
| Male | 1 | 2021 | 351098 | 0.010 |
Why?
|
| Female | 1 | 2021 | 382129 | 0.010 |
Why?
|
| Models, Biological | 1 | 2015 | 9443 | 0.010 |
Why?
|
| Mutation | 1 | 2021 | 29620 | 0.010 |
Why?
|
| Neoplasms | 1 | 2021 | 21681 | 0.010 |
Why?
|